How to Get CagriSema Online in Belgium

Many patients in Belgium are interested in CagriSema for weight loss. It's important to know that CagriSema is currently not approved for prescription in the EU, including Belgium, and remains in clinical trials. Consequently, Hi-Doctor does not offer or prescribe CagriSema at this time. Here, we explain what CagriSema is and, more importantly, what safe, EU-approved weight-loss treatments you can access today through an EU-licensed doctor.

What is CagriSema, and why isn't it a normal option yet?

CagriSema is an investigational drug developed by Novo Nordisk, combining two active components: semaglutide (a GLP-1 receptor agonist, found in Ozempic and Wegovy) and cagrilintide (an amylin analogue). This combination is designed to offer a multi-faceted approach to weight management and metabolic control. While early clinical trials have shown promising results for significant weight loss, CagriSema has not yet received regulatory approval from the European Medicines Agency (EMA) or any national health authorities in the EU. This means it cannot be legally prescribed or sold in Belgium or any other EU country. Seeking CagriSema from unregulated online sources carries significant health risks, as such products may be counterfeit, improperly dosed, or contaminated, and lack medical supervision.

Proven weight-loss medications available online today

While CagriSema is not yet an option, several highly effective and EMA-approved medications are available for weight management. These treatments are prescribed by EU-licensed doctors based on individual patient suitability and medical history.

• Ozempic (semaglutide): A GLP-1 receptor agonist, typically prescribed for type 2 diabetes but also used off-label for weight management in some cases.
• Wegovy (semaglutide): A higher-dose formulation of semaglutide specifically approved for chronic weight management in eligible patients.
• Mounjaro (tirzepatide): A dual GLP-1 and GIP receptor agonist, approved for type 2 diabetes and showing significant efficacy in weight loss.
• Saxenda (liraglutide): A GLP-1 receptor agonist, approved for chronic weight management and administered daily.

How to get a weight-loss prescription online in Belgium

Hi-Doctor offers a straightforward, safe, and fully compliant process to access approved weight-loss medications from an EU-licensed doctor, valid in Belgium:

1. Complete a medical questionnaire: Fill out a detailed, confidential online form (takes 2-3 minutes) about your health and medical history.
2. Doctor review: An EU-licensed doctor reviews your case individually, usually within 24 hours. They assess your suitability for treatment and ensure it's medically appropriate.
3. Receive your e-prescription: If approved, you'll receive a REMPE electronic prescription (Spanish standard, valid EU-wide) as a downloadable PDF in your secure patient account and via email. This typically happens within 24 hours of doctor approval.
4. Pick up at any pharmacy: Present your e-prescription at any pharmacy in Belgium or any other EU country, thanks to cross-border prescription directive 2011/24/EU. The online consultation fee is a flat €25, and if the doctor determines treatment is not appropriate, this fee is automatically refunded.

Why choose Hi-Doctor over unregulated peptide sellers

Choosing Hi-Doctor means prioritizing your health and safety. We connect you with EU-licensed doctors who provide genuine medical oversight. Our prescriptions are for real, EMA-approved medications dispensed by regulated pharmacies, ensuring traceability and quality. We operate under strict RGPD compliance, safeguarding your data. With over 50,000 patients served and a 4.8 Trustpilot rating, Hi-Doctor offers a trustworthy and secure alternative to the risks associated with unregulated 'research chemicals' or grey-market peptide vendors that lack medical supervision and guarantee of product authenticity.